Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer

Autor: Bavi Prashant, Al-Dayel Fouad, Abubaker Jehad, Ahmed Maqbool, Bu Rong, Uddin Shahab, Al-Kuraya Khawla S
Jazyk: angličtina
Rok vydání: 2009
Předmět:
Zdroj: Molecular Cancer, Vol 8, Iss 1, p 74 (2009)
Druh dokumentu: article
ISSN: 1476-4598
DOI: 10.1186/1476-4598-8-74
Popis: Abstract Background Recent epidemiological studies have suggested that obesity is associated with ovarian cancer. Obesity hormone leptin and its receptor (Ob-R) contribute to tumor development by enhancing cell growth and survival. This study was design to investigate the prevalence of leptin and Ob-R in Middle Eastern epithelial ovarian cancer (EOC) and to analyze the role of leptin and the mechanisms under its action in EOC tissue sample and cell lines. Methods The expression of leptin and Ob-R was examined by immunohistochemistry in a tissue microarray of 156 EOC samples. Proliferation of EOC cells in response to leptin was assessed by MTT assays, and its anti-apoptotic effects were determined by flow cytometry. Effect of leptin on PI3K/AKT signaling pathway was further determined by western blotting. Results In clinical samples, Ob-R overexpression was seen in 59.2% EOCs and was significantly associated with poor progression free survival (p = 0.0032). Furthermore, Ob-R expression was associated with anti apoptotic proteins Bcl-XL (p = 0.0035) and XIAP (p = 0.0001). In vitro analysis using EOC cell lines showed that leptin stimulated cell proliferation and inhibits apoptosis via activation of PI3K/AKT signaling pathway. Inhibition of PI3K activity by LY294002, a specific inhibitor of PI3-kinase abrogated leptin mediated PI3K/AKT signaling. Gene silencing of Ob-R with Ob-R siRNA in EOC cells resulted in down regulation of phospho-AKT and its down stream targets. Conclusion Our findings have potential clinical implication for EOC development and progression.
Databáze: Directory of Open Access Journals